Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg. 2018;28(12):3783–94.
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.
Thereaux J, Lesuffleur T, Czernichow S, et al. Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort study. Lancet Diabetes Endocrinol. 2019;7(10):786–95.
Oor JE, Roks DJ, Unlu C, Hazebroek EJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67.
Felsenreich DM, Langer FB, Kefurt R, et al. Update: 10 Years of Sleeve Gastrectomy-the First 103 Patients. Obes Surg. 2018;28(11):3586–94.
Santoro S, Velhote MC, Malzoni CE, et al. Rev Bras Videocir. 2004;2:130–8.
Santoro S, Malzoni CE, Velhote MC, et al. Digestive Adaptation with Intestinal Reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16(10):1371–9.
Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10.
Santoro S, Milleo FQ, Malzoni CE, et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008;18(1):17–26.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016;39(6):861–77.
Article CAS PubMed Google Scholar
Papamargaritis D, le Roux CW, Sioka E, et al. Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2013;9(2):192–201.
Zhao S, Li R, Zhou J, Sun Q, Wang W, Wang D. Sleeve gastrectomy with transit bipartition: a review of the literature. Expert Rev Gastroenterol Hepatol. 2023;17(5):451–9.
Article CAS PubMed Google Scholar
Mui WL, Lee DW, Lam KK. Laparoscopic sleeve gastrectomy with loop bipartition: A novel metabolic operation in treating obese type 2 diabetes mellitus. Int J Surg Case Rep. 2014;5(2):56–8.
Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: Gastric bipartition, a novel metabolic surgery procedure: A retrospective cohort study. Int J Surg. 2016;34:28–34.
Article CAS PubMed Google Scholar
Emile SH, Madyan A, Mahdy T, et al. Systematic review of the outcome of single-anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity and metabolic syndrome. Int J Surg. 2021;91:105981.
Khalaf M, Hamed H. Single anastomosis sleeve ileal bypass: 2 years outcome. Obes Surg. 2021;31(4):1510–8.
Sewefy AM, Atyia AM, Mohammed MM, et al. Single anastomosis sleeve jejunal (SAS-J) bypass as a treatment for morbid obesity, technique and review of 1986 cases and 6 Years follow-up: Retrospective cohort. Int J Surg. 2022;102:106662.
Sewefy AM, Saleh A. The outcomes of single anastomosis sleeve jejunal bypass as a treatment for morbid obesity (Two-year follow-up). Surg Endosc. 2021;35(10):5629–38.
Reiser M, Christogianni V, Nehls F, et al. Short-term Results of Transit Bipartition to Promote Weight Loss After Laparoscopic Sleeve Gastrectomy. Ann Surg Open. 2021;2(4):e102.
Article PubMed PubMed Central Google Scholar
Ataya M, Faris S, El-Sayes IA, et al. Single anastomosis sleeve ileal (SASI) bypass: an updated systematic review and meta-analysis. Surg Obes Relat Dis. 2024;20(8):763–74.
Wang J, Ni L, Li T, et al. Incidence of de novo gastroesophageal reflux disease following sleeve gastrectomy versus sleeve gastrectomy with transit bipartition: a retrospective cohort study. Surg Endosc. 2025. https://doi.org/10.1007/s00464-025-12276-1.
Genser L, Carandina S, Tabbara M, et al. Presentation and surgical management of leaks after mini-gastric bypass for morbid obesity. Surg Obes Relat Dis. 2016;12(2):305–12.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Valezi AC, Campos ACL, Bahten LCV. Brazilian Multi-Society Position Statement on emerging bariatric and metabolic surgical procedures. Arq Bras Cir Dig. 2023;36:e1759.
Article PubMed PubMed Central Google Scholar
Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.
Qin C, Sun C, Huang D, et al. Comparison of single anastomosis sleeve ileal bypass and laparoscopic sleeve gastrectomy in treatment of obesity: a retrospective study. Surg Endosc. 2025;39(1):358–67.
Chen X, Yang G, Ding WY, et al. Duodenogastric reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg. 1998;2(3):260–8.
Wolfe BM, Kvach E, Eckel RH. Treatment of Obesity: Weight Loss and Bariatric Surgery. Circ Res. 2016;118(11):1844–55.
Comments (0)